Laboratory Corporation of America (LH)

Overall impact
C (47)

Commentary

Laboratory Corporation of America is an average overall performer. With a 'C' rating of 46.6 for overall impact (34th percentile compared to all companies), Laboratory Corporation of America ranks 71st out of 76 industry peers, behind IMAC, Enzo Biochem, Invitae and 67 others, and ahead of Bio-Rad Laboratories, Lonza, Natera and 2 others. On top material causes for Laboratory Corporation of America's industry (Healthcare Software & Services), Laboratory Corporation of America performs well in Equal Pay and Opportunity (87.9 score) and Quality Lifelong Education (84.5) and performs poorly in Improved Mental Health (29.4 score), Reduced Use of tobacco (12.3), Reduced Waste (38.0) and 6 other causes where it received a 'D' or 'F' score.
Impact
Cause LH
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Founded
1976
Employees
71,000
Sector
Health Care
Industry
Biotechnology
Sub-industry
Biotechnology
SASB industry
Health Care Delivery
Headquarters
Nc, United States
Share classes
LH
Mission
To improve health and improve lives -- LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care.
Description
Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations (MCOs). In addition, the company offers online and mobile applications that enable patients to check offerings, schedule PSC visits, check-in upon PSC arrival, complete documentation, access tests and test results, and manage their accounts; online applications for providers, MCOs, and accountable care organizations; specimen collection services; and drug development, medical device, and companion diagnostic development solutions, as well as support for crop protection and chemical testing. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; and MCOs, employer plans, other health insurance providers, governments, physician, large provider organizations, other healthcare providers, hospitals and health systems, patients and consumers, crop protection and chemical companies, academic institutions, independent clinical laboratories, and retailers. The company was founded in 1995 and is headquartered in Burlington, North Carolina.
Material causes
Ethos considers the following causes material for Laboratory Corporation of America, based on its industry sub-industry Biotechnology. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.